佛塑科技(000973.SZ):擬與廣新研究院等設立項目公司研發偏光片用液晶塗布膜
格隆匯8月18日丨佛塑科技(000973.SZ)公佈,擬與廣東省廣新創新研究院有限公司(簡稱廣新研究院)、佛山緯達光電材料股份有限公司共同投資設立項目公司,研發偏光片用液晶塗布膜。公司與廣新研究院、緯達光電本着資源整合共享、平等互利的原則,擬共同出資設立項目公司,註冊資本4,000萬元人民幣,其中廣新研究院出資2,000萬元,佔比50%,佛塑科技出資500萬元,佔比12.50%,緯達光電出資1,500萬元,佔比37.50%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.